MicroRNAs and target molecules in bladder cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Bladder cancer (BC) is a prevalent malignancy with complex origins involving genetic and signaling pathway alterations.
• MicroRNAs (miRNAs) play crucial roles in cellular processes and are implicated in BC pathogenesis.
• Aberrant miRNA expression in tumors can influence gene activity, driving oncogenic or tumor-suppressive functions.

Purpose of the Study:

• To comprehensively review recent findings on the role of various miRNAs in bladder cancer.
• To elucidate the potential of miRNAs as biomarkers for BC diagnosis, prognosis, and treatment.
• To provide insights for developing novel diagnostic and therapeutic strategies for BC.

Main Methods:

• Literature review of recent studies on miRNAs in bladder cancer.
• Analysis of miRNA expression patterns and their functional implications in BC.
• Evaluation of miRNA-based biomarker potential in blood, urine, and tissue samples.

Main Results:

• miRNAs are significantly dysregulated in bladder cancer tissues.
• Specific miRNAs show potential as biomarkers for early detection, prognosis, and predicting treatment response.
• miRNAs regulate key cellular pathways involved in BC development, including cell growth and apoptosis.

Conclusions:

• miRNAs are critical players in bladder cancer and hold significant promise as biomarkers.
• Further research into miRNA biomarkers can enhance BC diagnosis, prognosis, and personalized treatment approaches.
• Understanding miRNA roles is essential for advancing bladder cancer management and control.